Charlestown, Massachusetts 02129


Purpose:

The purpose of this study is to create a subject database to recruit for current and future studies in research on autism and other neurodevelopmental disabilities.


Study summary:

Aim 1: to recruit people interested in research on autism and other neurodevelopmental disabilities Aim 2: to complete a diagnostic assessment, to confirm the diagnosis of autism spectrum disorder or other developmental disability (e.g., developmental language delay) in our patient population and rule out a diagnosis of autism spectrum disorder and other comorbid conditions in our control group Aim 3: to maintain subject information in a database, from which we can recruit for our studies


Criteria:

Inclusion Criteria: - Typically-developing, healthy adolescents and adults (ages 14-32) - Adolescents and adults with autism spectrum disorder (ages 14-32) Exclusion Criteria: - Extreme premature birth (<34 weeks) - Known genetic disorders related to autism (e.g. Fragile X) - Recent diagnosis of psychosis (within 6 months) - Some other psychiatric diagnoses may be excluded following screening (e.g. Tourette's syndrome). - Metal implants / permanent retainers / hair dyes with metallic components


NCT ID:

NCT00549731


Primary Contact:

Principal Investigator
Tal Kenet, Ph.D
Massachusetts General Hospital

Nicole McGuiggan, Rsch Coord
Phone: 617-966-9766
Email: TRANSCEND@partners.org


Backup Contact:

N/A


Location Contact:

Charlestown, Massachusetts 02129
United States



There is no listed contact information for this specific location.

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.